Intracellular autofluorescence: A biomarker for epithelial cancer stem cells

Nature Methods

Volumn 11, Issue 11, 2014, Pages 1161-1169

  Miranda Lorenzo, Irene ^a   Dorado, Jorge ^a   Lonardo, Enza ^a   Alcala, Sonia ^a   Serrano, Alicia G ^a   Clausell Tormos, Jenifer ^a   Cioffi, Michele ^a   Megias, Diego ^a   Zagorac, Sladjana ^a   Balic, Anamaria ^a   Hidalgo, Manuel ^a   Erkan, Mert ^b   Kleeff, Joerg ^b   Scarpa, Aldo ^c   Sainz, Bruno ^a   Heeschen, Christopher ^a,d  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF VERONA   (Italy)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; CD133 ANTIGEN; CELL SURFACE MARKER; CHEMOKINE RECEPTOR CXCR4; GEMCITABINE; HERMES ANTIGEN; LIPOCORTIN 5; RETINOIC ACID; RIBOFLAVIN; ABC TRANSPORTER; ABCG2 PROTEIN, HUMAN; ATG12 PROTEIN, HUMAN; LIGHT CHAIN 3, HUMAN; MICROTUBULE ASSOCIATED PROTEIN; SUMO PROTEIN; TUMOR MARKER; TUMOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOFLUORESCENCE; AUTOPHAGY; BLEACHING; CANCER CHEMOTHERAPY; CANCER STEM CELL; CARCINOGENICITY; CELL RENEWAL; CONFOCAL MICROSCOPY; CYTOPLASM; CYTOPLASM VESICLE; EPITHELIAL CANCER CELL LINE; FEMALE; FLOW CYTOMETRY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRACELLULAR AUTOFLUORESCENCE; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PANCREATIC CANCER CELL LINE; PHENOTYPE; PRIMARY TUMOR; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; BIOSYNTHESIS; CELL SEPARATION; COLORECTAL TUMOR; FLUORESCENCE IMAGING; LIVER CELL CARCINOMA; LIVER TUMOR; LUNG TUMOR; METABOLISM; NON SMALL CELL LUNG CANCER; NUDE MOUSE; PANCREAS CARCINOMA; PANCREAS TUMOR; PATHOLOGY; PROCEDURES; TUMOR CELL CULTURE;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; AUTOPHAGY; CARCINOMA, HEPATOCELLULAR; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, PANCREATIC DUCTAL; CELL SEPARATION; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MICE; MICE, NUDE; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; NEOPLASTIC STEM CELLS; OPTICAL IMAGING; PANCREATIC NEOPLASMS; RIBOFLAVIN; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 84908605558     PISSN: 15487091     EISSN: 15487105     Source Type: Journal    
DOI: 10.1038/nmeth.3112     Document Type: Article

References (37)

1. Clarke, M.F, et al. Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res. 66, 9339-9344 (2006
2. Campbell, L.L. &Polyak, K. Breast tumor heterogeneity: cancer stem cells or clonal evolution? Cell Cycle 6, 2332-2338 (2007
3. Balic, A., Dorado, J., Alonso-Gómez, M. &Heeschen, C. Stem cells as the root of pancreatic ductal adenocarcinoma. Exp. Cell Res. 318, 691-704 (2012
4. Hermann, P.C., Bhaskar, S., Cioffi, M. &Heeschen, C. Cancer stem cells in solid tumors. Semin. Cancer Biol. 20, 77-84 (2010
5. Al-Hajj, M., Wicha, M.S., Benito-Hernandez, A., Morrison, S. &Clarke, M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 100, 3983-3988 (2003
6. Gallmeier, E, et al. Inhibition of ataxia telangiectasia- And Rad3-related function abrogates the in vitro and in vivo tumorigenicity of human colon cancer cells through depletion of the CD133+ tumor-initiating cell fraction. Stem Cells 29, 418-429 (2011
7. Wicha, M.S., Liu, S. &Dontu, G. Cancer stem cells: an old idea-A paradigm shift. Cancer Res. 66, 1883-1890 (2006
8. Beier, D, et al. CD133+ and CD133- glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res. 67, 4010-4015 (2007
9. Joo, K.M, et al. Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas. Lab. Invest. 88, 808-815 (2008
10. Ogden, A.T, et al. Identification of A2B5+CD133- Tumor-initiating cells in adult human gliomas. Neurosurgery 62, 505-514 (2008
11. Wang, J, et al. CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells. Int. J. Cancer 122, 761-768 (2008
12. Hermann, P.C, et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1, 313-323 (2007
13. Zhang, S.N., Huang, F.T., Huang, Y.J., Zhong, W. &Yu, Z. Characterization of a cancer stem cell-like side population Derived from human pancreatic adenocarcinoma cells. Tumori 96, 985-992 (2010
14. Zhou, J, et al. Persistence of side population cells with high drug efflux capacity in pancreatic cancer. World J. Gastroenterol. 14, 925-930 (2008
15. Kabashima, A, et al. Side population of pancreatic cancer cells predominates in TGF-β-mediated epithelial to mesenchymal transition and invasion. Int. J. Cancer 124, 2771-2779 (2009
16. Broadley, K.W, et al. Side population is not necessary or sufficient for a cancer stem cell phenotype in glioblastoma multiforme. Stem Cells 29, 452-461 (2011
17. Burkert, J., Otto, W.R. &Wright, N.A. Side populations of gastrointestinal cancers are not enriched in stem cells. J. Pathol. 214, 564-573 (2008
18. Clément, V, et al. Retraction: Marker-independent identification of glioma-initiating cells. Nat. Methods 10, 1035 (2013
19. Lonardo, E, et al. Nodal/Activin signaling drives self-renewal and tumorigenicity of pancreatic cancer stem cells and provides a target for combined drug therapy. Cell Stem Cell 9, 433-446 (2011
20. Iliopoulos, D., Hirsch, H.A., Wang, G. &Struhl, K. Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion. Proc. Natl. Acad. Sci. USA 108, 1397-1402 (2011
21. Hermann, P.C. &Heeschen, C. Metastatic cancer stem cells-quo vadis? Clin. Chem. 59, 1268-1269 (2013
22. Hermann, P.C, et al. Multimodal treatment eliminates cancer stem cells and leads to long-Term survival in primary human pancreatic cancer tissue xenografts. PLoS ONE 8, e66371 (2013
23. Cicalese, A, et al. The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells. Cell 138, 1083-1095 (2009
24. Santini, D, et al. Prognostic role of human equilibrative transporter 1 (hENT1) in patients with resected gastric cancer. J. Cell. Physiol. 223, 384-388 (2010
25. Rabindran, S.K., Ross, D.D., Doyle, L.A., Yang, W. &Greenberger, L.M. Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein. Cancer Res. 60, 47-50 (2000
26. Bell, D.H. Characterization of the fluorescence of the antitumor agent, mitoxantrone. Biochim. Biophys. Acta 949, 132-137 (1988
27. White, E. Deconvoluting the context-dependent role for autophagy in cancer. Nat. Rev. Cancer 12, 401-410 (2012
28. van Herwaarden, A.E, et al. Multidrug transporter ABCG2/breast cancer resistance protein secretes riboflavin (vitamin B2) into milk. Mol. Cell. Biol. 27, 1247-1253 (2007
29. Jonker, J.W, et al. The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria. Proc. Natl. Acad. Sci. USA 99, 15649-15654 (2002
30. van Herwaarden, A.E. &Schinkel, A.H. The function of breast cancer resistance protein in epithelial barriers, stem cells and milk secretion of drugs and xenotoxins. Trends Pharmacol. Sci. 27, 10-16 (2006
31. Ifergan, I., Goler-Baron, V. &Assaraf, Y.G. Riboflavin concentration within ABCG2-rich extracellular vesicles is a novel marker for multidrug resistance in malignant cells. Biochem. Biophys. Res. Commun. 380, 5-10 (2009
32. Mueller, M.T, et al. Combined targeted treatment to eliminate tumorigenic cancer stem cells in human pancreatic cancer. Gastroenterology 137, 1102-1113 (2009
33. Qin, D., Xia, Y. &Whitesides, G.M. Soft lithography for micro- And nanoscale patterning. Nat. Protoc. 5, 491-502 (2010
34. Sainz, B. Jr, et al. Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor. Nat. Med. 18, 281-285 (2012
35. Sainz, B. Jr., Barretto, N. &Uprichard, S.L. Hepatitis C virus infection in phenotypically distinct Huh7 cell lines. PLoS ONE 4, e6561 (2009
36. Greenwood, M. &Yule, G.U. On the statistical interpretation of some bacteriological methods employed in water analysis. J. Hyg. (Lond.) 16, 36-54 (1917
37. Taswell, C. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J. Immunol. 126, 1614-1619 (1981